GO:0009234 menaquinone biosynthetic process: Vitamin K2 Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0009234 (menaquinone biosynthetic process) describes the biochemical steps that build menaquinones (vitamin K2), molecules with a methylated naphthoquinone ring and a variable-length unsaturated isoprenoid side chain.
• Menaquinones are essential electron carriers in bacterial respiratory chains and are also produced in humans via the UBIAD1 enzyme, linking the pathway to mitochondrial function and cell growth control.
• The pathway is best studied in bacteria such as Bacillus subtilis and Corynebacterium glutamicum, where menaquinone is a key component of respiratory supercomplexes.
• Microbial methylmenaquinones expand the redox chemistry of the pathway and are important for anaerobic respiration and organohalide reduction.
• Menaquinone-7 (MK-7) is a commercially important nutraceutical produced by fermentation, and process intensification studies have improved its biosynthesis and recovery.
• Dysregulation of menaquinone-related metabolism has been linked to renal clear cell carcinoma and to metabolic markers in diabetic models, making the pathway a target for disease research.
Description
Menaquinone biosynthetic process (GO:0009234) is the set of chemical reactions and pathways that produce menaquinones, a family of lipid-soluble quinones also known as vitamin K2. Structurally, menaquinones consist of a methylated naphthoquinone ring and a side chain of variable numbers of unsaturated isoprenoid residues. This pathway is conserved across many bacteria and is also present in humans through the UBIAD1 enzyme, which synthesizes menaquinone-4. Because menaquinones participate in electron transport and oxidative phosphorylation, understanding their biosynthesis is central to microbiology, mitochondrial biology, and nutrition. In bacteria, menaquinone biosynthesis is essential for respiratory energy conservation, and the pathway is a validated target for antimicrobial development. In humans, UBIAD1 (also known as TERE1) is a menaquinone biosynthetic enzyme whose ectopic expression inhibits renal clear cell carcinoma cell growth and alters cholesterol and lipid metabolism. Menaquinone-7 (MK-7) is a commercially important form of vitamin K2 produced by fermentation, and bioprocess optimization has been a focus of industrial research. Recent studies also show that MK-7 supplementation can affect advanced glycation end-products and oxidation markers in diabetic animal models, highlighting the systemic impact of this pathway. For researchers, GO:0009234 provides a structured framework to annotate genes, interpret omics data, and design experiments that probe menaquinone function in health and disease. This article summarizes the definition, mechanism, key genes, disease links, and research methods for menaquinone biosynthetic process, with a focus on how CRISPR-based models can accelerate discovery.
menaquinone biosynthetic process At A Glance
| GO ID | GO:0009234 |
|---|---|
| GO term | menaquinone biosynthetic process |
| Ontology | biological_process |
| Synonym | menaquinone anabolism; menaquinone biosynthesis; menaquinone formation; menaquinone synthesis; menatetrenone biosynthesis; menatetrenone biosynthetic process; multiprenylmenaquinone biosynthesis; multiprenylmenaquinone biosynthetic process; vitamin K2 biosynthesis; vitamin K2 biosynthetic process |
| Major function | Production of menaquinones (vitamin K2) that serve as electron carriers in respiratory chains and as enzyme cofactors |
| Key structural feature | Methylated naphthoquinone ring with a variable-length unsaturated isoprenoid side chain |
| Representative organisms | Bacteria (e.g., Bacillus subtilis, Corynebacterium glutamicum) and humans (via UBIAD1) |
| Related disease examples | Renal clear cell carcinoma, metabolic disorders, and bacterial infections |
What Is GO:0009234?
GO:0009234 (menaquinone biosynthetic process) is defined as the chemical reactions and pathways resulting in the formation of any of the menaquinones. Menaquinones are structurally characterized by a methylated naphthoquinone ring and side chains composed of a variable number of unsaturated isoprenoid residues. Menaquinones that have vitamin K activity are known as vitamin K2. The term encompasses all biosynthetic routes, including those producing menatetrenone (MK-4) and multiprenylmenaquinones such as MK-7.
Why Is menaquinone biosynthetic process Important in Cell Biology?
Menaquinone biosynthetic process is important because menaquinones are essential for electron transport and energy metabolism in bacteria and for vitamin K2-dependent functions in humans. In bacteria, the pathway supports respiration and is a target for antibiotics. In humans, UBIAD1-mediated menaquinone synthesis influences cell growth, lipid metabolism, and oxidative stress, with implications for cancer and metabolic disease. Understanding this pathway also enables biotechnological production of MK-7 for nutraceuticals.
• Provides menaquinones that act as electron carriers in bacterial and mitochondrial respiratory chains.
• Supports vitamin K2-dependent gamma-carboxylation of proteins involved in coagulation and bone health.
• UBIAD1 (TERE1) is a human menaquinone biosynthetic enzyme whose expression inhibits renal clear cell carcinoma growth.
• Methylmenaquinones expand the redox range of microbial respiration and organohalide reduction.
• Menaquinone biosynthesis is a validated target for antimicrobial drug discovery.
• MK-7 production by fermentation is an industrial biotechnology target.
• MK-7 supplementation alters advanced glycation end-products and oxidation markers in diabetic rats.
• The pathway links to cholesterol and lipid metabolism through SXR target genes.
What Happens During menaquinone biosynthetic process?
Formation of the naphthoquinone ring
In simple terms: The cell builds the core ring structure of menaquinone from simple precursor molecules.
The biosynthesis of menaquinones begins with the construction of the methylated naphthoquinone ring. In bacteria, this involves the conversion of chorismate or related intermediates through a series of enzymatic steps. The ring provides the redox-active quinone moiety essential for electron transfer. In humans, UBIAD1 catalyzes the prenylation of menadione to form menaquinone-4, a key step in vitamin K2 synthesis.
Attachment of the isoprenoid side chain
In simple terms: A lipid tail of variable length is attached to the ring, making the molecule fat-soluble.
Menaquinones are distinguished by their side chains composed of a variable number of unsaturated isoprenoid residues. The length of this side chain determines the menaquinone species, such as MK-4 or MK-7. In bacteria, prenyltransferases catalyze the addition of prenyl units to the ring precursor. In humans, UBIAD1 uses geranylgeranyl diphosphate to prenylate menadione, producing MK-4. The side chain length affects membrane localization and biological activity.
Methylation and modification of the ring
In simple terms: Chemical groups are added to the ring to create the final active menaquinone.
Following ring formation and side-chain attachment, methylation steps occur to produce the mature menaquinone. In microbial systems, methylmenaquinones are synthesized by specific methyltransferases that add methyl groups to the naphthoquinone ring. These modifications influence the redox potential and biological function of the molecule. The exact enzymes vary among species, but the overall logic of ring methylation is conserved.
Integration into respiratory chains
In simple terms: The finished menaquinone is inserted into the cell membrane to help generate energy.
Once synthesized, menaquinones are incorporated into the cytoplasmic membrane where they function as electron carriers in respiratory chains. In Corynebacterium glutamicum, menaquinone is a component of the respiratory supercomplex, facilitating electron transfer between dehydrogenases and terminal oxidases. This integration is essential for oxidative phosphorylation and energy conservation. In bacteria, menaquinone also supports anaerobic respiration and organohalide reduction.
Regulation and metabolic integration
In simple terms: The cell adjusts menaquinone production based on its energy needs and environment.
Menaquinone biosynthesis is regulated in response to respiratory demand and environmental conditions. In bacteria, the pathway is coordinated with other respiratory components to maintain optimal electron transport. In humans, UBIAD1 expression is linked to cholesterol and lipid metabolism through SXR target genes, suggesting cross-talk between menaquinone synthesis and broader metabolic networks. This integration ensures that menaquinone levels match cellular requirements.
Key Genes Involved in GO:0009234 menaquinone biosynthetic process
The following genes and proteins are experimentally implicated in menaquinone biosynthetic process or its regulation, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UBIAD1 (TERE1) | Human menaquinone-4 biosynthetic enzyme; prenylates menadione | Inhibits renal clear cell carcinoma growth; alters cholesterol and lipid metabolism |
| menA | Bacterial enzyme for menaquinone biosynthesis (e.g., in Bacillus subtilis) | Model for studying menaquinone pathway and respiratory function |
| menB | Bacterial naphthoquinone ring synthesis | Target for antimicrobial development |
| menC | Bacterial menaquinone biosynthesis | Conserved pathway enzyme |
| menD | Bacterial menaquinone biosynthesis | Involved in early ring formation |
| menE | Bacterial menaquinone biosynthesis | Required for menaquinone production |
| menF | Bacterial menaquinone biosynthesis | Species-specific isochorismate synthase |
| menG | Methyltransferase for menaquinone ring methylation | Produces methylmenaquinones |
| menH | Bacterial menaquinone biosynthesis | Part of the canonical pathway |
| menI | Bacterial menaquinone biosynthesis | Involved in ring modification |
| ubiE | Methyltransferase in ubiquinone/menaquinone biosynthesis | Shared with ubiquinone pathway |
| ubiF | Bacterial menaquinone biosynthesis | Related to ring modification |
| CrtE | Prenyltransferase for side-chain synthesis | Provides isoprenoid precursors |
| HepT | Methylmenaquinone biosynthesis in some bacteria | Methylation of menaquinone |
| RdhA | Organohalide oxidoreductase using menaquinol | Menaquinone-dependent respiration |
| SXR (NR1I2) | Nuclear receptor regulating UBIAD1 target genes | Links menaquinone synthesis to lipid metabolism |
How Is menaquinone biosynthetic process Regulated?
Menaquinone biosynthetic process is regulated at multiple levels. In bacteria, the pathway is coordinated with respiratory chain components to match electron transport demand, as seen in Corynebacterium glutamicum supercomplex assembly. In humans, UBIAD1 expression is modulated by the SXR nuclear receptor and is associated with altered cholesterol and lipid metabolism, indicating transcriptional regulation by metabolic signals. Additionally, menaquinone biosynthesis can be influenced by substrate availability and redox state, though specific regulators vary by organism.
menaquinone biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UBIAD1 | Renal clear cell carcinoma; altered cholesterol and lipid metabolism | UBIAD1 knockout and overexpression in renal carcinoma cell lines |
| menA | Bacterial respiratory deficiency; antimicrobial target | menA knockout in Bacillus subtilis |
| menB | Bacterial infection; menaquinone-dependent respiration | menB knockout in pathogenic bacteria |
| menG | Methylmenaquinone production; anaerobic respiration | menG knockout in Corynebacterium glutamicum |
| RdhA | Organohalide respiration; bioremediation | RdhA knockout in organohalide-respiring bacteria |
Menaquinone biosynthesis and cancer
UBIAD1 (TERE1), a human menaquinone biosynthetic enzyme, is downregulated in renal clear cell carcinoma, and its ectopic expression inhibits cancer cell growth. This inhibition is associated with altered metabolic phenotype, reactive oxygen species, nitric oxide, and SXR target genes involved in cholesterol and lipid metabolism. These findings suggest that menaquinone biosynthesis may suppress tumor growth through metabolic reprogramming.
Menaquinone biosynthesis and metabolic disorders
Menaquinone-7 supplementation in Zucker diabetic fatty rats increased multiple advanced glycation end-products and oxidation markers, indicating that vitamin K2 status can influence metabolic and oxidative stress pathways in diabetes. This links menaquinone biosynthesis and supplementation to systemic metabolic regulation.
Menaquinone biosynthesis as an antimicrobial target
The menaquinone biosynthetic pathway is essential for bacterial respiration and is a validated target for anti-infective drug discovery. Inhibitors of menaquinone biosynthesis, such as immucillins, have been explored for infectious diseases, highlighting the therapeutic potential of targeting this pathway.
From menaquinone biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does UBIAD1 loss promote renal carcinoma growth? | UBIAD1 knockout in renal clear cell carcinoma cell lines |
| Does UBIAD1 overexpression alter lipid metabolism? | UBIAD1 overexpression in cancer cells |
| Is menA essential for bacterial respiration? | menA knockout in Bacillus subtilis |
| Does menG methylation affect menaquinone redox potential? | menG point mutation in Corynebacterium glutamicum |
| Can MK-7 production be enhanced by pathway engineering? | Knock-in of prenyltransferase genes in Bacillus subtilis |
| Does menaquinone supplementation affect diabetic markers? | Zucker diabetic fatty rat model with MK-7 supplementation |
How to Study the menaquinone biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of menaquinone biosynthetic genes | Expression profiling in bacteria and human cells |
| LC-MS metabolomics | Menaquinone species (MK-4, MK-7) and intermediates | Quantification in fermentation and animal models |
| Enzymatic assays | Prenyltransferase and methyltransferase activity | Characterization of UBIAD1 and bacterial enzymes |
| CRISPR knockout | Gene essentiality and pathway function | Bacterial and human cell models |
| Structural biology (cryo-EM) | Menaquinone-dependent enzyme complexes | Mechanistic studies of respiratory supercomplexes |
| Fermentation optimization | MK-7 yield and recovery | Industrial production of vitamin K2 |
| Animal supplementation studies | Advanced glycation end-products and oxidation markers | Diabetic rat models |
Genomic and transcriptomic analysis
RNA-seq and comparative genomics can identify menaquinone biosynthetic gene clusters and their expression patterns across bacterial species. In Corynebacterium glutamicum, transcriptomic studies have revealed coordinated expression of respiratory supercomplex components, including menaquinone-related genes. In humans, expression profiling of UBIAD1 in cancer cells has shown links to SXR target genes.
Metabolomics and lipidomics
Mass spectrometry-based metabolomics can quantify menaquinone species such as MK-4 and MK-7 in cells and tissues. These methods have been used to measure MK-7 levels in fermentation processes and in animal models after supplementation. Lipidomics can also assess the impact of menaquinone biosynthesis on membrane composition.
Enzymatic assays and structural biology
In vitro enzymatic assays using purified UBIAD1 or bacterial menaquinone enzymes can measure prenylation and methylation activities. Structural studies of membrane-bound menaquinol:organohalide oxidoreductase have provided insights into menaquinone-dependent electron transfer. These approaches help define substrate specificity and catalytic mechanisms.
Microbial genetics and CRISPR interference
CRISPR-based knockout and knockdown in bacteria such as Bacillus subtilis and Corynebacterium glutamicum enable functional dissection of menaquinone biosynthetic genes. These models can reveal essentiality, pathway flux, and respiratory phenotypes. In human cells, CRISPR knockout of UBIAD1 can test its role in cancer cell growth and metabolism.
How CRISPR Can Be Used to Study GO:0009234 menaquinone biosynthetic process
Knockout
CRISPR knockout of menaquinone biosynthetic genes such as UBIAD1 in human cells or menA in bacteria can reveal their essentiality and impact on respiration, growth, and metabolism. For example, UBIAD1 knockout in renal carcinoma cells can test whether loss of menaquinone synthesis promotes tumor growth. In bacteria, menA knockout can confirm the requirement for menaquinone in respiratory chains.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes in menaquinone biosynthetic enzymes to dissect catalytic residues. For instance, mutating the active site of UBIAD1 can clarify its prenyltransferase mechanism. In bacteria, point mutations in menG can alter methylation activity and menaquinone species.
Knock-in
CRISPR knock-in can insert tags or reporter genes into menaquinone biosynthetic loci to track expression and localization. Tagged UBIAD1 knock-in can enable imaging of the enzyme in living cells. In industrial strains, knock-in of prenyltransferase genes can enhance MK-7 production.
Overexpression
CRISPR activation or cDNA overexpression can increase menaquinone biosynthetic enzyme levels. Overexpression of UBIAD1 in cancer cells inhibits growth and alters lipid metabolism, providing a model to study its tumor-suppressive functions. In bacteria, overexpression of menaquinone pathway genes can boost vitamin K2 yields.
How EDITGENE Supports menaquinone biosynthetic process Research
Researchers studying menaquinone biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway function, disease progression, or metabolic regulation. EDITGENE provides CRISPR-based cell models and screening services to enable these investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for menaquinone biosynthetic process research.
Frequently Asked Questions About menaquinone biosynthetic process
What is menaquinone biosynthetic process?
It is the set of biochemical reactions that produce menaquinones (vitamin K2), molecules with a methylated naphthoquinone ring and an isoprenoid side chain, as defined by GO:0009234.
What genes are involved in menaquinone biosynthetic process?
Key genes include UBIAD1 in humans and menA, menB, menC, menD, menE, menF, menG, menH, and menI in bacteria, among others.
What is the function of menaquinone in bacteria?
Menaquinones act as electron carriers in respiratory chains, supporting oxidative phosphorylation and anaerobic respiration.
How is menaquinone related to vitamin K2?
Menaquinones with vitamin K activity are known as vitamin K2, and they are products of the menaquinone biosynthetic process.
What diseases are linked to menaquinone biosynthesis?
Renal clear cell carcinoma, metabolic disorders, and bacterial infections have been associated with menaquinone pathway components.
What is the role of UBIAD1 in menaquinone synthesis?
UBIAD1 is a human enzyme that prenylates menadione to produce menaquinone-4, and its expression inhibits renal carcinoma cell growth.
How can CRISPR be used to study menaquinone biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression can be applied to menaquinone genes to test function, essentiality, and disease relevance.
What is menaquinone-7 (MK-7)?
MK-7 is a menaquinone with a seven-unit isoprenoid side chain, commercially produced by fermentation and used as a vitamin K2 supplement.
Does menaquinone supplementation affect diabetes?
In Zucker diabetic fatty rats, MK-7 supplementation increased advanced glycation end-products and oxidation markers, indicating metabolic effects.
What methods are used to study menaquinone biosynthetic process?
Common methods include RNA-seq, LC-MS metabolomics, enzymatic assays, CRISPR screens, and structural biology.
Conclusion
Menaquinone biosynthetic process (GO:0009234) is a fundamental pathway for producing vitamin K2 and menaquinone electron carriers in bacteria and humans. Its components, from UBIAD1 to bacterial men genes, are implicated in cancer, metabolic disease, and infection, making the pathway a rich area for research. CRISPR-based models and multi-omics approaches are powerful tools to dissect its regulation and therapeutic potential. As the demand for vitamin K2 nutraceuticals grows and the links to human disease deepen, precise genetic models will be essential. EDITGENE's CRISPR services can support every step from gene discovery to functional validation in menaquinone biosynthetic process research.
References
- 1. Halder M et al.. 2019. Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease.. Int J Mol Sci 20(4) PMID: 30791399
- 2. Fredericks WJ et al.. 2013. Ectopic expression of the TERE1 (UBIAD1) protein inhibits growth of renal clear cell carcinoma cells: altered metabolic phenotype associated with reactive oxygen species, nitric oxide and SXR target genes involved in cholesterol and lipid metabolism.. Int J Oncol 43(2):638-52 PMID: 23759948
- 3. Evans GB et al.. 2018. Immucillins in Infectious Diseases.. ACS Infect Dis 4(2):107-117 PMID: 29151351
- 4. Cimmino L et al.. 2023. Structure of a membrane-bound menaquinol:organohalide oxidoreductase.. Nat Commun 14(1):7038 PMID: 37923808
- 5. Wilkens D et al.. 2023. Biosynthesis and function of microbial methylmenaquinones.. Adv Microb Physiol 83:1-58 PMID: 37507157
- 6. Berenjian A et al.. 2014. Designing of an intensification process for biosynthesis and recovery of menaquinone-7.. Appl Biochem Biotechnol 172(3):1347-57 PMID: 24173914
- 7. Mrosewski I et al.. 2025. Menaquinone-7 Supplementation Increases Multiple Advanced Glycation End-Products and Oxidation Markers in Zucker Diabetic Fatty Rats.. Nutrients 17(17) PMID: 40944124
- 8. Moe A et al.. 2022. The respiratory supercomplex from C. glutamicum.. Structure 30(3):338-349.e3 PMID: 34910901
